← Oncology Approval Tracker

FDA DECISION ·

Jemperli

dostarlimab-gxly · GlaxoSmithKline

Accelerated approvalNew or expanded indicationTumor-agnostic solid tumors
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Adults with recurrent or advanced dMMR solid tumors by an FDA-approved test, with progression during or after prior treatment and no satisfactory alternatives.

LAMPGEN ANALYSIS

Why it matters

This is a biomarker-defined solid tumor indication across primary sites.

What research teams should watch

Capture the primary tumor, MMR method and clinical assessment of alternative treatments.

PRIMARY RECORDS

Sources